Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. Patients less than 75 years of age were eligible if they had stage III/IV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback